Tecan Group AG

SWX:TECN Aktierapport

Börsvärde: CHF 1.5b

Tecan Group Framtida tillväxt

Future kriterier kontrolleras 4/6

Tecan Group förväntas öka intäkter och intäkter med 52.4% respektive 6.1% per år. EPS förväntas tillväxt med 50.4% per år. Avkastningen på eget kapital förväntas bli 8.7% om 3 år.

Viktig information

52.4%

Tillväxttakt i vinsten

50.40%

Tillväxttakt för EPS

Life Sciences vinsttillväxt19.0%
Intäkternas tillväxttakt6.1%
Framtida avkastning på eget kapital8.71%
Bevakning av analytiker

Good

Senast uppdaterad27 Apr 2026

Senaste uppdateringarna om framtida tillväxt

Recent updates

TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings

The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.

TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations

Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.

TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings

The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.

TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations

Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.

TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E

Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.

TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential

Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.

TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside

Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.

TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings

Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.

Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?

Dec 23
Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?

TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential

Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.

TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements

Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.

TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026

Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price

Nov 06
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price

TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value

The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.

Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?

Oct 22
Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.

Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet

Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet

Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price

Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price

Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price

Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price

At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?

Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?

Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 08
Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely

Apr 04
Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely

Is Tecan Group (VTX:TECN) Using Too Much Debt?

Apr 01
Is Tecan Group (VTX:TECN) Using Too Much Debt?
User avatar

Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production

Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.

Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk

Jan 12
Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk

A Look At The Fair Value Of Tecan Group AG (VTX:TECN)

Dec 21
A Look At The Fair Value Of Tecan Group AG (VTX:TECN)

Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable

Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable

These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well

Sep 21
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well

Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%

Aug 16
Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%

Is Tecan Group (VTX:TECN) Using Too Much Debt?

Jun 14
Is Tecan Group (VTX:TECN) Using Too Much Debt?

Calculating The Fair Value Of Tecan Group AG (VTX:TECN)

Apr 20
Calculating The Fair Value Of Tecan Group AG (VTX:TECN)

Tecan Group AG's (VTX:TECN) Business Is Yet to Catch Up With Its Share Price

Apr 02
Tecan Group AG's (VTX:TECN) Business Is Yet to Catch Up With Its Share Price

Prognoser för vinst- och omsättningstillväxt

SWX:TECN - Analytikernas framtida uppskattningar och tidigare finansiella data (CHF Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
12/31/20281,05382821417
12/31/202797785731539
12/31/202688447751328
12/31/2025882-111103138N/A
9/30/2025895-24118152N/A
6/30/202590763134165N/A
3/31/202592065126157N/A
12/31/202493468118149N/A
9/30/202496785105135N/A
6/30/20241,00010193122N/A
3/31/20241,037117109141N/A
12/31/20231,074132126161N/A
9/30/20231,088120114151N/A
6/30/20231,102109101140N/A
3/31/20231,12311597134N/A
12/31/20221,14412192128N/A
9/30/20221,11011391129N/A
6/30/20221,07710589129N/A
3/31/20221,012113110149N/A
12/31/2021947122130170N/A
9/30/2021911136163203N/A
6/30/2021875150195237N/A
3/31/2021803127181223N/A
12/31/2020731104167208N/A
9/30/202069194142177N/A
6/30/202065184118146N/A
3/31/20206447996122N/A
12/31/2019637737599N/A
9/30/201962770N/A95N/A
6/30/201961667N/A90N/A
3/31/201960569N/A92N/A
12/31/201859471N/A93N/A
9/30/201858270N/A99N/A
6/30/201857069N/A106N/A
3/31/201855967N/A103N/A
12/31/201754966N/A99N/A
9/30/201753662N/A93N/A
6/30/201752357N/A86N/A
3/31/201751556N/A102N/A
12/31/201650655N/A119N/A
9/30/201649155N/A124N/A
6/30/201647655N/A129N/A
3/31/201645856N/A114N/A
12/31/201544057N/A99N/A
9/30/201543452N/A83N/A
6/30/201542748N/A67N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: TECN förväntas bli lönsam under de kommande 3 åren, vilket anses vara snabbare än sparkvoten ( 0.5% ).

Resultat vs marknad: TECN förväntas bli lönsam under de kommande 3 åren, vilket anses överstiga genomsnittet på marknaden.

Höga tillväxtresultat: TECN förväntas bli lönsam under de kommande 3 åren.

Intäkt vs marknad: TECN s intäkter ( 6.1% per år) förväntas växa snabbare än Swiss marknaden ( 4.8% per år).

Hög tillväxtintäkter: TECN s intäkter ( 6.1% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: TECN s avkastning på eget kapital förväntas bli låg om 3 år ( 8.7 %).

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/02 10:36
Aktiekurs vid dagens slut2026/04/30 00:00
Intäkter2025/12/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Tecan Group AG bevakas av 21 analytiker. 9 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Leonildo DelgadoBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Markus MayerBaader Helvea Equity Research